2nd Quarter - Report

TIBER CREEK GROUP for JAZZ PHARMACEUTICALS

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to the FDA and Health and Human Services pertaining to CBD policies; Issues related to the regulation of intoxicating hemp.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
MATTHEW LEFFINGWELL —
TIMOTHY A MOLINO —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Issues related to cannabis research; Issues related to the FDA; Issues related to cannabis research at Health and Human Services.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
MATTHEW LEFFINGWELL —
TIMOTHY A MOLINO —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

Issues related to FDA enforcement of non-FDA approved, cannabis derived CBD products in H.R. 4121/S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; Issues related to the Ag/FDA amendment - technical correction to hemp in H.R. 4121/S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; Issues related to intoxicating hemp products.

LobbyistCovered position, as disclosed
MATTHEW LEFFINGWELL —
TIMOTHY A MOLINO —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4121 (119th), S. 2256 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.